Michael Storek
Company: Sanofi
Job title: Head of Complement Cluster
Seminars:
Panel Discussion: Uncovering the Latest Technology in Preclinical Modelling Through the Promise of Humanized Complement Models in Drug Development 9:30 am
Evaluating the utility of humanized complement models for testing complement inhibitors Delving into their advantages for human targeted agents Addressing key challenges such as incomplete humanization, low human protein expression and functional assay development Understanding how humanized complement models can be used to inform complement inhibitor dose predictionRead more
day: Conference Day Two
Panel Discussion: Discussing the Next-Generation of Novel Modalities to be Used for Enhanced Delivery & Broader Impact in CNS & Ophthalmic Indications 12:30 pm
Addressing the critical challenge of achieving sufficient complement inhibitor exposure in the CNS, a major reason for past failures with peripherally acting drugs Exploring novel delivery modalities like gene therapy, shuttle technologies that are in early development, to unlock the therapeutic potential of complement inhibition neurodegenerative diseases Highlighting the significant appeal and ongoing development of…Read more
day: Conference Day Two